Product

Wegovy is an injectable prescription medicine designed for adults with obesity (BMI ≥30) or overweight (BMI ≥27) who also have weight-related medical problems. It helps them lose weight and maintain it by working alongside a reduced-calorie meal plan and increased physical activity. Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, which helps regulate appetite and food intake.

Key Benefits:

• Effective Weight Management: Helps reduce body weight and maintain it over time.
• Cardiovascular Health: Reduces the risk of major cardiovascular events in adults with established heart disease.
• Convenient Dosage: Single-use pre-filled pen delivering doses of 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, or 2.4 mg.

Important Safety Information:

• Should not be used with other semaglutide-containing products or GLP-1 receptor agonists.
• Possible side effects include thyroid tumors, pancreatitis, and mental health issues.
• Consult your healthcare provider before use if you have a history of pancreatitis, thyroid cancer, or other medical conditions